Alpex Pharma

About:

Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet).

Website: http://www.alpex.com/en/

Top Investors: Signet Healthcare Partners, BB Biotech Ventures

Description:

Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) called also "fast melt" and effervescent tablets. Alpex Pharma has developed a unique proprietary covering ODT technology. The high production capacity and advanced R&D technologies makes Alpex Pharma to be one of the most important company of the world in the field of fast melt and effervescent tablets. The company has a state-of-the-art manufacturing and R&D facilities of some 7000 square meters, with separate pharmaceutical and nutritional plant GMP compliant.

Total Funding Amount:

$9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Mezzovico, Ticino, Switzerland

Founded Date:

1983-01-01

Contact Email:

contact(AT)alpex.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai